CHEK2*1100delC homozygosity in the Netherlands—prevalence and risk of breast and lung cancer

The 1100delC mutation in the CHEK2 gene has a carrier frequency of up to 1.5% in individuals from North-West Europe. Women heterozygous for 1100delC have an increased breast cancer risk (odds ratio 2.7). To explore the prevalence and clinical consequences of 1100delC homozygosity in the Netherlands,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Huijts, Petra EA, Hollestelle, Antoinette, Balliu, Brunilda, Houwing-Duistermaat, Jeanine J, Meijers, Caro M, Blom, Jannet C, Ozturk, Bahar, Krol-Warmerdam, Elly MM, Wijnen, Juul, Berns, Els MJJ, Martens, John WM, Seynaeve, Caroline, Kiemeney, Lambertus A, van der Heijden, Henricus F, Tollenaar, Rob AEM, Devilee, Peter, van Asperen, Christi J
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2014
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3865411/
https://ncbi.nlm.nih.gov/pubmed/23652375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ejhg.2013.85
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker